Surveillance of antimalarial drug resistance in China in the 1980s-1990s

Infectious Diseases of Poverty

Volumn 3, Issue 1, 2014, Pages

  Liu, De quan ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Antimalarial drugs; in vitro; in vivo; Plasmodium falciparum; Resistance; Sensitivity; Surveillance

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; CHLOROQUINE; MEFLOQUINE; PIPERAQUINE; PYRONARIDINE;

ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CHINA; CONCENTRATION RESPONSE; DRUG INHIBITION; DRUG SURVEILLANCE PROGRAM; DRUG USE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT;

EID: 84919484137     PISSN: None     EISSN: 20499957     Source Type: Journal    
DOI: 10.1186/2049-9957-3-8     Document Type: Article

References (51)

1. Payne D. Spread of chloroquine resistance in Plasmodium falciparum J. Parasitol Today 1987, 3:241-246. 10.1016/0169-4758(87)90147-5, 15462966.
2. Suebsaeng L, Wernsdorfer WH, Rooney W. Sensitivity to quinine and mefloquine of Plasmodium falciparum in Thailand. Bull WHO 1986, 64:759-765. 2490964, 3542267.
3. ter Kuile FO, Dolan G, Nosten F, Edstein MD, Luxemburger C, Phaipun L, Chongsuphajaisiddhi T, Webster HK, White NJ. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet 1993, 341:1044-1049. 10.1016/0140-6736(93)92409-M, 8096956.
4. Murphy GS, Basri H, Purnomo, Andersen EM, Bangs MJ, Mount DL, Gorden J, Lal AA, Purwokusumo AR, Harjosuwarno S, Hoffman SL. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 1993, 341:96-100. 10.1016/0140-6736(93)92568-E, 8093414.
5. Looareesuwan S, Buchachart K, Wilairatana P, Chalermrut K, Rattanapong Y, Amradee S, Siripiphat S, Chullawichit S, Thimasan K, Ittiverakul M, Triampon A, Walsh DS. Primaquine-tolerant vivax malaria in Thailand. Ann Trop Med Parasitol 1997, 91:939-943.
6. Che LG, Chen WC, Yang HL, Huang KG. Report on the survey of geographical distribution of chloroquine-resistant strain of Plasmodium falciparum in Yunnan province. Chin J Epidemiol 1986, 7(2):88-91. in Chinese.
7. Yang HL, Yang PF, Dong Y, Che LG, Liu DQ, Liu RJ, Zhan B, Zhang CY, Gao DQ. Longitudinal surveillance of the resistance of Plasmodium falciparum to chloroquine in Yunnan Province. Chin J Parasitol Parasitic Dis 1994, 12(1):31-33. in Chinese.
8. Cai XZ, Pang XJ, Chen WJ, Li H, Ren DX. Investigation on the sensitivity of Plasmodium falciparum to chloroquine at Qianjia, Hainan Island. Chin J Prev Med 1982, 16(1):6-9. in Chinese.
9. Cai XZ, Pang XJ, Zeng QQ, Chen WJ, Wang XF, Zhang HJ, Wu Z, Huang QL, Ren DX, Liu DQ, Qiu CP. The result of 10-year investigation of chloroquine-resistant Plasmodium falciparum in Hainan Island. Chin J Epidemiol 1986, 7(2):92-95. in Chinese.
10. WHO Technical Report Series Chemotherapy of malaria and resistance of antimalarials 1973, Geneva: Report of a WHO Scientific Group, WHO Technical Report Series.
11. Rieckmann KH, Campbell GH, Sax LJ, Mrema JE. Drug sensitivity of Plasmodium falciparum. An in-vitro microtechnique. Lancet 1978, 1:22-23.
12. WHO Instruction for use of the microtest kit for the assessment of the response of Plasmodium falciparum to chloroquine and mefloquine in vitro> 1981, Geneva, WHO.
13. Division of Control of Tropical Diseases World Health Organisation. In vitro micro-test (Mark III) for assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine/pyrimethamine and artemisinin 2001, 2. World Health Organization CTD/MAL/97.20 Rev, Division of Control of Tropical Diseases.
14. World Health Organization Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated flaciparum malaria 2003, 50. WHO/HTM/RBM/, World Health Organization.
15. World Health Organization Recommended Genotyping Procedures (RGPs) to identify parasite populations. Developed after an informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization 2007, Amsterdam, Netherland, World Health Organization.
16. Liu DQ, Ren DX, Liu RJ. Preparation of the lyophilized culture medium for in vitro microtest of chloroquine-resistant Plasmodium falciparum and improvement of chloroquine-coated plate. J Parasitol Parasitic Dis 1983, 1(1):44-48. in Chinese.
17. Liu DQ, Ren DX, Liu RJ, Qiu CP, Gao DQ. A culture medium easy for field test on the drug resistance of Plasmodium falciparum. Chin J Parasitol Parasitic Dis 1989, 7(2):112-113. in Chinese.
18. Liu DQ, Ren DX Qiu CP, Liu RJ. Comparison of the efficacy of two culture media for in vitro microtest on the sensitivity of Plasmodiumfalciparum to chloroquine and mefloquine. Chin J Parasitol Parasitic Dis 1986, 4(4):256-258. in Chinese.
19. Ren DX, Liu DQ, Liu RJ. Sensitivity of Plasmodium falciparum in Hainan Island to chloroquine by the in vitro microtechnique. Acta Microbiol Sin 1981, 21:510-512. in Chinese.
20. Huang QL, Zhu Z, Ren DX, Liu DQ, Qiu CP, Liu RJ, Lin CF, Yang XP. A successive survey on the sensitivity of Plasmodium falciparum patients to chloroquine by in vitro microtechnique and in vivo test in Hainan Island. Chin J Prev Med 1985, 19(4):220-222. in Chinese.
21. Liu DQ, Qiu CP, Liu RJ, Ren DX. Resistance degree of Plasmodium falciparum to chloroquine and its geographical distribution in China. Chin J Parasitol Parasitic Dis 1986, 4(2):81-85. in Chinese.
22. Onori E, Vu Thi P. Is Plasmodium falciparum resistance to chloroquine reversible in absence of drug pressure?. Lancet 1986, 1:319.
23. Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qiu CP, Cai XZ, Lin CF, Liang AH. Alteration in resistance of Plasmodium falciparum to chloroquine after cessation of chloroquine medication for twelve years. Chin J Parasitol Parasitic Dis 1992, 12(4):241-244. in Chinese.
24. Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qui CP, Cai XZ, Ling CF, Song AH, Tang X. Changes in the resistance of Plasmodium falciparum to chloroquine in China. Bull World Health Organ 1995, 73:483-486. 2486789, 7554020.
25. Liu DQ, Cai XZ, Ren DX, Liu RJ, Lin SG, Zeng LH, Tang X. Changes in chloroquine resistance of Plasmodium falciparum in Hainan province. Chin J Parasitol Parasitic Dis 1999, 17(1):32-34. in Chinese.
26. Liu DQ, Feng XP, Yang HL, Lin SG, Chen WJ, Yang PF. Fluctuation in the resistance of Plasmodium falciparum to chloroquine in China. Chin J Parasitol Parasitic Dis 2005, 23(1):27-31. in Chinese.
27. Yang HL, He H. A report of one artemether-resistant falciparum malaria case. Chin J Parasitol Parasitic Dis 1991, 9(2):125. in Chinese.
28. Yang HL, Yang PF, Liu DQ, Liu RJ, Dong Y, Zhang CY, Gao DQ, He H. In vitro test on the sensitivity of Plasmodium falciparum to chloroquine, pyronaridine, srtesunate and piperaquine in south Yunnan. Chin J Parasitol Parasitic Dis 1992, 10(3):198-200. in Chinese.
29. Yang HL, Yang PF, Yang YM. In vitro test on the sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, sulfadoxine/pyrimethamine and pyronaridine in south Yunnan. Chin J Parasitol Parasitic Dis 1994, 12(2):140-142. in Chinese.
30. Yang HL, Liu DQ, Huang KG, Yang YM, Yang PF, Liao MZ, Zhang CY. In vitro assay of the sensitivity of Plasmodium falciarum to chloroquine, amodiaquine, piperaquine, mefloquine and quinine in Yunnan province. Chin J Parasitol Parasitic Dis 1999, 17(1):43-45. in Chinese.
31. Yang HL, Liu DQ, Huang KG, Yang PF, Yang YM, Liao MZ, Zhang CY, Liu RJ. In vitro assay of the sensitivity of Plasmodium falciparum to the derivatives of artemisimin, pyronaridine and chloroquine in Yunnan. Chin J Parasitol Parasitic Dis 1997, 15(5):292-296. in Chinese.
32. Yang HL, Liu DQ, Huang KG, Zhang CY, Li CF. Longitudinal surveillance of the sensitivity of Plasmodium falciparum to pyronaridine in south Yunnan. Chin J Parasitol Parasitic Dis 1998, 16(2):81-83. in Chinese.
33. Cai XZ. Investigation of piperaquine resistance of Plasmodium falciparum and its treatment in Hainan Island. Hainan Health 1989, 17(4):4-8. in Chinese.
34. Wu Z, Huang QL, Zhang KY. Piperaquine resistance of Plasmodium falciparum in Hainan Island. Chin Med J (Engl) 1985, 65:483.
35. Zhang KY, Zhou JX, Wu Z, Huang QL. In vitro assay on the sensitivity of Plasmodium falciparum to chloroquine, piperaquine, amodiaquine, mefloquine and quinine. Chin J Parasitol Parasitic Dis 1987, 5(3):165. in Chinese.
36. Qiu CP, Liu DQ, Liu RJ, Ren DX. Surveillane on sensitivity of Plasmodium falciparum to pyronaridine and artesunate. Chin J PPrev Med 1982, 22:368. in Chinese.
37. Liu DQ, Liu RJ, Zhang CY, Cai XZ, Tang X, Yang HL, Yang PF, Dong Y. Present situation on the sensitivity of plasmodium falciparum to antimalarial drugs in China. Chin J Parasitol Parasitic Dis 1996, 14(1):37-41. in Chinese.
38. WHO Regional Office for the Western Pacific Resistance of Plasmodium falciparum and policies for treatment of falciparum malaria. Proceeding of the Informal consultation on monitoring resistance to antimalarial drugs in the Mekong region 2000, 16-17. Phnom Penh, Cambodia, WHO Regional Office for the Western Pacific.
39. WHO The use of artermisinin and its derivatives as antimalarial drugs (Archived) 1998, 10-12. Geveva: Report of a Joint CTD/DMP/TDR Informal Consultation, WHO.
40. Roll Back Malaria/WHO The use of antimalarial drugs 2000, 13-17. Geveva: Report of a WHO Info Consultation, Roll Back Malaria/WHO.
41. Roll Back Malaria/WHO Antimalarial drug combination therapy 2001, 4-5. Geveva: Report of a WHO Tech Consultation, Roll Back Malaria/WHO.
42. Bunnag D, Karbwang J, Harinasuta T. Artemether in the treatment of multiple drug resistant falciparum malaria [J]. Southeast Asian J Trop Med Public Health 1992, 23:762-767.
43. Liu DQ, Lin SG, Feng XP, Chen WJ, Chen FL, Wu HM, Chen C, Liu J. Study on treatment of multi-drug resistant falciparum malaria by using a combination of dihydroartemisinin and pyronaridine. Chin J Parasitol Parasitic Dis 2002, 20(4):193-196. in Chinese.
44. Huang QL, Ouyang WC, Zhou JX, Wu Z, Zhang KY, Huang JK, Cai XZ, Pang XJ, Fu SG, Wang XF, Liu J. Effectiveness of amodiaquine, sulfadoxine-pyrimethamine and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China. Bull World Health Organ 1988, 66(3):353-358. 2491139, 3048759.
45. Che LG, Zhang YL, Li XL, Shu WY, Zhang X, Li CF, Liu ZH. Clinical study on the treatment of drug-resistant Plasmodium falciparum with compound artemether tablet. Chin J Parasitic Dis Control 1995, 8(4):244-245. in Chinese.
46. Expert Advisory Committee on Malaria, Ministry of Health, China Principles for antimalarial drug use in China. Chin J Parasitic Dis Control 2002, 15(3):129-130. in Chinese, Expert Advisory Committee on Malaria, Ministry of Health, China.
47. Malaria Commission, Committee of Medical Sciences Malaria situation in the People's Republic of China in 1984. Chin J Parasitol Parasitic Dis 1985, 3(4):241-243. in Chinese, Malaria Commission, Committee of Medical Sciences.
48. Zhou SS, Wang Y, Li Y. Malaria situation in the People's Republic of China in 2010. Chin J Parasitol Parasitic Dis 2011, 29(6):401-403. in Chinese.
49. Bloland PB. Drug resistance in malaria. WHO/CDS/CSR/DRS 2001, 10:6-8.
50. White NJ. Preventing antimalarial drug resistance through combinations. Drug Res Updates 1998, 1:3-9.
51. White NJ. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci 1999, 354:739-749. 10.1098/rstb.1999.0426, 1692562, 10365399.